Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (COPD): The AURA Study (BY217/M2-124)
Public ClinicalTrials.gov record NCT00297102. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Effect of Roflumilast on Exacerbation Rate in Patients With COPD. The AURA Study
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The aim of the study is to investigate the effect of roflumilast on exacerbation rate and pulmonary function in patients with chronic obstructive pulmonary disease (COPD). Roflumilast will be administered orally once daily in the morning at one dose level. The study duration will last up to 56 weeks. The study will provide further data on safety and tolerability of roflumilast. For additional information (for US patients only) see www.COPDSTUDY.net or dial 866-788-2673 (toll free).
Study identification
- NCT ID
- NCT00297102
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,523 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 2006 (Type not available)
- Primary completion
- Jul 2008 (Actual)
- Completion
- Sep 2008 (Actual)
- Last update posted
- Jan 16, 2017
2006 – 2008
United States locations
- U.S. sites
- 47
- U.S. states
- 26
- U.S. cities
- 46
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Altana Pharma/Nycomed Investigational Site | Fullerton | California | 92385 | — |
| Altana Pharma/Nycomed Investigational Site | Los Angeles | California | 90025 | — |
| Altana Pharma/Nycomed Investigational Site | Los Angeles | California | 90048 | — |
| Altana Pharma/Nycomed Investigational Site | Palmdale | California | 93551 | — |
| Altana Pharma/Nycomed Investigational Site | Rancho Mirage | California | 92270 | — |
| Altana Pharma/Nycomed Investigational Site | San Diego | California | 92120 | — |
| Altana Pharma/Nycomed Investigational Site | Bay Pines | Florida | 33708 | — |
| Altana Pharma/Nycomed Investigational Site | Miami | Florida | 33176 | — |
| Altana Pharma/Nycomed Investigational Site | Panama City | Florida | 32405 | — |
| Altana Pharma/Nycomed Investigational Site | Atlanta | Georgia | 30309 | — |
| Altana Pharma/Nycomed Investigational Site | Marietta | Georgia | 30060 | — |
| Altana Pharma/Nycomed Investigational Site | Hines | Illinois | 60141 | — |
| Altana Pharma/Nycomed Investigational Site | South Bend | Indiana | 46617 | — |
| Altana Pharma/Nycomed Investigational Site | Lebanon | Kentucky | 40291 | — |
| Altana Pharma/Nycomed Investigational Site | Metairie | Louisiana | 70006 | — |
| Altana Pharma/Nycomed Investigational Site | New Orleans | Louisiana | 70112 | — |
| Altana Pharma/Nycomed Investigational Site | Slidell | Louisiana | 70461 | — |
| Altana Pharma/Nycomed Investigational Site | Sunset | Louisiana | 70584 | — |
| Altana Pharma/Nycomed Investigational Site | Bangor | Maine | 04401 | — |
| Altana Pharma/Nycomed Investigational Site | Baltimore | Maryland | 21224 | — |
| Altana Pharma/Nycomed Investigational Site | North Dartmouth | Massachusetts | 02777 | — |
| Altana Pharma/Nycomed Investigational Site | Edina | Minnesota | 55435 | — |
| Altana Pharma/Nycomed Investigational Site | Minneapolis | Minnesota | 55407 | — |
| Altana Pharma/Nycomed Investigational Site | Chesterfield | Missouri | 63017 | — |
| Altana Pharma/Nycomed Investigational Site | St Louis | Missouri | 63117 | — |
| Altana Pharma/Nycomed Investigational Site | Billings | Montana | 59102 | — |
| Altana Pharma/Nycomed Investigational Site | Missoula | Montana | 59804 | — |
| Altana Pharma/Nycomed Investigational Site | Lincoln | Nebraska | 68510 | — |
| Altana Pharma/Nycomed Investigational Site | Omaha | Nebraska | 68114 | — |
| Altana Pharma/Nycomed Investigational Site | Reno | Nevada | 89502 | — |
| Altana Pharma/Nycomed Investigational Site | Cherry Hill | New Jersey | 08003 | — |
| Altana Pharma/Nycomed Investigational Site | Springfield | New Jersey | 07081 | — |
| Altana Pharma/Nycomed Investigational Site | New York | New York | 10029 | — |
| Altana Pharma/Nycomed Investigational Site | Winston-Salem | North Carolina | 27103 | — |
| Altana Pharma/Nycomed Investigational Site | Cincinnati | Ohio | 45241 | — |
| Altana Pharma/Nycomed Investigational Site | Columbus | Ohio | 43215 | — |
| Altana Pharma/Nycomed Investigational Site | Toledo | Ohio | 43614 | — |
| Altana Pharma/Nycomed Investigational Site | Youngstown | Ohio | 44501 | — |
| Altana Pharma/Nycomed Investigational Site | Lake Oswego | Oregon | 97035 | — |
| Altana Pharma/Nycomed Investigational Site | Philadelphia | Pennsylvania | 19140 | — |
| Altana Pharma/Nycomed Investigational Site | Cranston | Rhode Island | 02920 | — |
| Altana Pharma/Nycomed Investigational Site | East Providence | Rhode Island | 02914 | — |
| Altana Pharma/Nycomed Investigational Site | Austin | Texas | 78750 | — |
| Altana Pharma/Nycomed Investigational Site | Dallas | Texas | 75231 | — |
| Altana Pharma/Nycomed Investigational Site | Charlottesville, VA | Virginia | 22908 | — |
| Altana Pharma/Nycomed Investigational Site | Bellingham | Washington | 98225 | — |
| Altana Pharma/Nycomed Investigational Site | Marietta | Wisconsin | 53717 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 132 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00297102, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 16, 2017 · Synced Oct 28, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00297102 live on ClinicalTrials.gov.